NCT05772780View on ClinicalTrials.gov

MP-3 Biofeedback Training and Central Vision Loss

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

February 9, 2022

Study Completion Date

February 9, 2022

Conditions
Age-Related Macular Degeneration
Interventions
DEVICE

MP-3 microperimeter

Biofeedback stimulation two days a week

DEVICE

MP-3 microperimeter

Biofeedback stimulation three days a week

Trial Locations (1)

00168

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome

All Listed Sponsors
lead

Amore Filippo

OTHER

NCT05772780 - MP-3 Biofeedback Training and Central Vision Loss | Biotech Hunter | Biotech Hunter